您好,欢迎登录Mr.confs会先生官方网站!

ICICIVR 2021: 15. International Conference on Immunotoxicology, Cellular Immunology and Vaccine Research

时间:2021-03-11 至 2021-03-12

ICICIVR 2021: 15. International Conference on Immunotoxicology, Cellular Immunology and Vaccine Research
收藏0
ICICIVR 2021: 15. International Conference on Immunotoxicology, Cellular Immunology and Vaccine Research
会议时间:2021-03-11 至 2021-03-12
会议地点: Miami, United States,Miami,United States 周边酒店预订

发票类型: 不支持开票
参会凭证:其它

门票信息
Participation Type Early Registration Fees Registration Fees
Non-Student Oral/Poster Presenter Registration € 450 € 500
Student Oral/Poster Presenter Registration € 350 € 400
Listener Registration € 250 € 300
Additional Paper Publication € 100
会议介绍

The International Research Conference Aims and Objectives

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers.

ICICIVR 2021: 15. International Conference on Immunotoxicology, Cellular Immunology and Vaccine Research aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Immunotoxicology, Cellular Immunology and Vaccine Research. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Immunotoxicology, Cellular Immunology and Vaccine Research

Call for Contributions

Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Immunotoxicology, Cellular Immunology and Vaccine Research are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.

Guidelines for Authors

Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for Full-Text Papers and Abstract Papers.

Please refer to the Paper Submission Guideline, Abstract Submission Guideline and Author Information before submitting your paper.

Conference Proceedings

All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the Open Science Index, Google Scholar, Semantic Scholar, Zenedo, OpenAIRE, BASE, WorldCAT, Sherpa/RoMEO, and other index databases. Impact Factor Indicators.

Special Journal Issues

ICICIVR 2021 has teamed up with the Special Journal Issue on Immunotoxicology, Cellular Immunology and Vaccine Research. A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.

Conference Sponsor and Exhibitor Opportunities

The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form.

Selected Papers

  1. Comparison of the Use of Vaccines or Drugs against Parasitic Diseases
    H. Al-Khalaifa, A. Al-Nasser
  2. Identification of Promiscuous Epitopes for Cellular Immune Responses in the Major Antigenic Protein Rv3873 Encoded by Region of Difference 1 of Mycobacterium tuberculosis
    Abu Salim Mustafa
  3. Displaying of GnRH Peptides on Bacteriophage T7 and Its Immunogenicity in Mice Model
    Hai Xu, Yiwei Wang, Xi Bao, Bihua Deng, Pengcheng Li, Yu Lu
  4. The Need for Including Hepatitis a Vaccine in Routine Childhood Immunization Programs in Europe as a Response to the Influx of Refugees from the Middle East and North Africa (MENA) Regions
    S. Ramia, N. Melhem, K. Kreidieh
  5. Vaccinated Susceptible Infected and Recovered (VSIR) Mathematical Model to Study the Effect of Bacillus Calmette-Guerin (BCG) Vaccine and the Disease Stability Analysis
    Muhammad Shahid, Nasir-uddin Khan, Mushtaq Hussain, Muhammad Liaquat Ali, Asif Mansoor
  6. Hepatitis B Virus Infection among Egyptian Children Vaccinated during Infancy
    Iman I. Salama, Samia M. Sami, Somaia I. Salama, Zeinab N. Said, Thanaa M. Rabah, Aida M. Abdel-Mohsin
  7. Unnoticeable Mumps Infection in India: Does MMR Vaccine Protect against Circulating Mumps Virus Genotype C?
    Jeevan Malayan, Aparna Warrier, Padmasani Venkat Ramanan, Sanjeeva Reddy N, Elanchezhiyan Manickan
  8. The Influence of Heat Treatment on Antimicrobial Proteins in Milk
    Jelena Zagorska, Inga Ciprovica
  9. Immune Responce in Mice Immunized with Live Cold-Adapted Influenza Vaccine in Combination with Chitosan-Based Adjuvants
    Nelly К. Akhmatova, Оlga V. Lebedinskaya, Ancha V. Baranova, Еlena А. Lebedinskaya, Ekaterina V. Sorokina, Elvin А. Akhmatov, Аnatoliy P. Godovalov, Stanislav G. Markushin
  10. Chitosan Nanoparticle as a Novel Delivery System for A/H1n1 Influenza Vaccine: Safe Property and Immunogenicity in Mice
    Nguyen Anh Dzung, Nguyen Thi Ngoc Hà, Dang Thi Hong Van, Nguyen Thi Lan Phuong, Nguyen Thi Nhu Quynh, Dinh Minh Hiep, Le Van Hiep
  11. Implementation of a “DIVA“ Concept withspecific Elisa Kits; When Subunit H5 Avian Influenza Vaccine is used
    Robles F, Uribe A, Guadarrama A , Castellanos L, González C.
Salam Abdo Einstein Medical Institute, US
Joseph Mattapallil Uniformed Services University, US
Dabbu Jaijyan Rutgers University, US
Lunthita Duthely University of Miami, US
Huailiang Ma university, US
Ankita Garg University of California San Diego, US
Nadeem Fazal Chicago State University, US
zheng ping University of Alabama at Birmingham, US
Rajan Thomas The Children's Hospital of Philadelphia, US
Debalina Sarkar University of Florida, US
Rahul Mittal Children's Hospital Los Angeles, US
Rolf Konig University of Texas Medical Branch, US
Chandan Thomas Lake Erie college of Osteopathic Medicine School of Pharmacy, US
Zhengwu Lu Abbott Laboratories, US
Wayne Jiang RayBiotech Inc, US
Randal Goomer Avrygen Corp., US
Andrew Deacon University of Greenwich, UK
Abid Ali National Institute of Biologicals, IN
Wenjuan Nie Beijing Chest Hospital, CN
Shraddha Rane The University of Manchester, GB
Rm Noah Universiti Kuala Lumpur, MY
Biljana Ilkovska Clinical Hospital Dr. Trifun Panovski, MK
Vladimir Jurisic University of Kragujevac, RS
Elham Mazaheri University of Modena and Reggio Emilia, IT
Blanca Peña Universidad Autonoma Agraria Antonio Narro, MX
Mohammad Islamuddin Jamia Millia Islamia University, IN
Josef Bodor Charles University, Biotechnology and Biomedical Center (BIOCEV), CZ
Kalaiselvan Asohan Thyrocare Technologies Limited, IN
Ranin Beshara Lebanese University and University of Lille, FR
Shuvomoy Banerjee JS Edusky, IN
会议日程
Abstracts/Full-Text Paper Submission Deadline   January 06, 2020
Notification of Acceptance/Rejection   January 28, 2020
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline   February 11, 2021
Conference Dates   March 11-12, 2021
参会指南
会议地点
×